“For 2025, the Swiss National Bank anticipates inflation at 0.3%, like Seco, while the KOF anticipates 0.5%,” recalls Arthur Jurus, for Oddo BHF. The expert from the Franco-German-Swiss establishment for his part expects 0.4% and therefore considers these projections “realistic”.
France reported unchanged inflation between November and December, at 1.3% year-on-year. The statements for Italy and especially for the euro zone as a whole are still to be published.
At 9:14 a.m., the Swiss Market Index (SMI) fell by 0.12% to 11,679.25 points, the Swiss Leader Index (SLI) by 0.01% to 1936.69 points and the Swiss Performance Index (SPI) fell by 0.01% to 1936.69 points. 0.09% to 15,602.93 points. Of the thirty main valuations, fifteen fell, fourteen rose and the good Roche remained stuck to the starting point.
The other pharmaceutical heavyweight Novartis shed 0.8%, without any particular indication, while the food liner Nestlé gained 0.1%.
Insurers were dragging their feet, like Swiss Re (-1.1%, bottom) and Zurich Insurance (-1%).
The construction chemist Sika (-0.3%), reacted weakly to the adjustment to “underweight” against “overweight” of its recommendation by Barclays.
The asset manager Partners Group (+4.2%) occupied the good end of the ranking, cheered up by a purchase recommendation made by UBS. The mouse giant Logitech (+2%) and the vacuum pump equipment manufacturer VAT Group (+1%) were visibly benefiting from the downturn in the chip segment.
Excluding SMI, wealth manager Julius Baer rebounded by 0.6%, which has just confirmed the sale of its activities in Brazil in an effort to optimize its equity ratio.
Helvetia (+0.7%) and Swissquote (+0.4%) also stood out. The online bank saw Jefferies raise its price target.
The designer of bone substitutes Kuros (+15%) stood out particularly, which joined forces with the services of Medtronic to distribute its Magnetos on the essential American market, among others. (AWP)
Swiss
